The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.
Clinical trial NCT06208072 · UNKNOWN
Trial details
- NCT number
- NCT06208072
- Sponsor
- Hippocration General Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.